Brief Announcement on Semi-annual Earnings for 2025
Filed with SSE · · 2 pages · Chinese
Shanghai Shyndec Pharmaceutical Co., Ltd. on 6ix
Earlier from Shanghai Shyndec Pharmaceutical
- Announcement on Implementation of Dividend Distribution for 2024
- Indicative Announcement on the Proposed Pre-Listing for Public Transfer of Equity Interests in a Controlling Subsidiary
- Announcement on Wholly-owned Subsidiary Obtaining Notice of Approval for Marketing Application of Chemical APIs
- Announcement on Resolutions of the 2024 Annual General Meeting
- Announcement on the Voluntary Information Disclosure of the Holding Subsidiary's Drug Passing the Consistency Evaluation for Generic Drugs
Later from Shanghai Shyndec Pharmaceutical
- Announcement on Resignation of Senior Management Member
- Announcement on Progress in Public Listing and Transfer of Equity of Holding Subsidiary
- Notice on Convening the 2nd Extraordinary General Meeting in 2025
- Announcement on Implementation of Semi-annual Dividend Distribution for 2025
- Announcement on the Wholly-owned Subsidiary Obtaining the Approval Notice for Drug Supplementary Application
Follow Shanghai Shyndec Pharmaceutical into a list and get an email when it puts out news.
Follow Shanghai Shyndec Pharmaceutical